ON-OFF PHENOMENON WITH LEVODOPA THERAPY IN PARKINSONISM. CLINICAL AND PHARMACOLOGIC CORRELATIONS AND THE EFFECTS OF INTRAMUSCULAR PYRIDOXINEFAHN S.1974; NEUROLOGY; U.S.A.; DA. 1974; VOL. 24; NO 5; PP. 431-441; BIBL. 35REF.Article

DIFFERENTIAL DIAGNOSIS OF TREMORS = DIAGNOSTIC DIFFERENTIEL DES TREMBLEMENTSFAHN S.1972; MED. CLIN. N. AMER.; U.S.A.; DA. 1972; VOL. 56; NO 6; PP. 1363-1375; BIBL. 21 REF.Serial Issue

REPORT ON HUNTINGTON'S DISEASE WORKSHOP.FAHN S.1977; BIOMEDICINE; FR.; DA. 1977; VOL. 26; NO 2; PP. 104-105Article

BIOCHEMISTRY OF THE BASAL GANGLIA. = BIOCHIMIE DES NOYAUX GRIS CENTRAUXFAHN S.1976; ADV. NEUROL.; NETHERL.; DA. 1976; VOL. 14; PP. 59-89; BIBL. 6 P. 1/2Article

TREATMENT OF CHOREIC MOVEMENTS WITH PERPHENAZINEFAHN S.1972; DIS. NERV. SYST.; U.S.A.; DA. 1972; VOL. 33; NO 10; PP. 653-658; BIBL. 1 P.Serial Issue

Parkinson disease, the effect of levodopa, and the ELLDOPA trialFAHN, S.Archives of neurology (Chicago). 1999, Vol 56, Num 5, pp 529-535, issn 0003-9942Article

DOUBLE-BLIND EVALUATION OF TRIHEXYPHENIDYL IN DYSTONIABURKE RE; FAHN S.1983; ADVANCES IN NEUROLOGY; ISSN 0091-3952; USA; DA. 1983; VOL. 37; PP. 189-192; BIBL. 2 REF.Article

CONSIDERATIONS IN THE MANAGEMENT OF PARKINSONISM.FAHN S; CALNE DB.1978; NEUROLOGY; U.S.A.; DA. 1978; VOL. 28; NO 1; PP. 5-7; BIBL. 19 REF.Article

TREATMENT OF VASCULAR HEMIBALLISM AND HEMICHOREA.JOHNSON WG; FAHN S.1977; NEUROLOGY; U.S.A.; DA. 1977; VOL. 27; NO 7; PP. 634-636; BIBL. 27 REF.Article

HUNTINGTON DISEASE: CLINICAL CARE AND EVALUATIONSHOULSON I; FAHN S.1979; NEUROLOGY; USA; DA. 1979; VOL. 29; NO 1; PP. 1-3; BIBL. 9 REF.Article

Future strategies for the treatment of Parkinson's diseaseFAHN, S.Advances in neurology. 1993, Vol 60, pp 636-640, issn 0091-3952Article

Clinical variants of idiopathic torsion dystoniaFAHN, S.Journal of neurology, neurosurgery and psychiatry. 1989, pp 96-100, issn 0022-3050, 5 p., supplArticle

PHYSIOLOGIC AND PATHOLOGIC TREMORS. DIAGNOSIS, MECHANISM, AND MANAGEMENT = TREMBLEMENTS PHYSIOLOGIQUES ET PATHOLOGIQUES. DIAGNOSTIC, MECANISME ET TRAITEMENTJANKOVIC J; FAHN S.1980; ANN. INTERN. MED.; ISSN 0003-4819; USA; DA. 1980; VOL. 93; NO 3; PP. 460-465; BIBL. 61 REF.Article

UNILATERAL PARKINSON'S DISEASE AND CONTRALATERAL TARDIVE DYSKINESIA: A UNIQUE CASE WITH SUCCESSFUL THERAPY THAT MAY EXPLAIN THE PATHOPHYSIOLOGY OF THESE TWO DISORDERSFAHN S; MAYEUX R.1980; J. NEUR. TRANSM., SUPPL.; AUT; DA. 1980; NO 16; PP. 179-185; BIBL. 15 REF.Article

DYSTONIA: A DISORDER OFTEN MISDIAGNOSED AS A CONVERSION REACTION.LESSER RP; FAHN S.1978; AMER. J. PSYCHIATRY; U.S.A.; DA. 1978; VOL. 135; NO 3; PP. 349-352; BIBL. 17 REF.Article

GENERAL DISCUSSION OF DRUG THERAPY IN DYSTONIA.ELDRIDGE R; FAHN S.1976; ADV. NEUROL.; NETHERL.; DA. 1976; VOL. 14; PP. 417-422; BIBL. 5 REF.Article

STABILITY OF ENZYMES IN POST-MORTEM RAT BRAIN.FAHN S; COTE LJ.1976; J. NEUROCHIM.; G.B.; DA. 1976; VOL. 26; NO 5; PP. 1039-1042; BIBL. 21 REF.Article

LONG-TERM EVALUATION OF AMANTADINE AND LEVODOPA COMBINATION IN PARKINSONISM BY DOUBLE-BLIND CROSSOVER ANALYSES. = EVALUATION A LONG TERME DE L'ASSOCIATION AMANTADINE-LEVODOPA DANS LE PARKINSONISME PAR DES ETUDES CROISEES EN DOUBLE AVEUGLEFAHN S; ISGREEN WP.1975; NEUROLOGY; U.S.A.; DA. 1975; VOL. 25; NO 8; PP. 695-700; BIBL. 16 REF.Article

CATECHOL-O-METHYLTRANSFERASE INHIBITION BY U-0521 INCREASES STRIATAL UTILIZATION OF LEVODOPARECHES A; DE HUA JIANG; FAHN S et al.1982; NAUNYN-SCHMIEDEBERG'S ARCHIVES OF PHARMACOLOGY; ISSN 0028-1298; DEU; DA. 1982; VOL. 320; NO 1; PP. 34-37; BIBL. 29 REF.Article

MORE ON MYOCLONUS IN ALZHEIMER DISEASEMAYEUX R; HUNTER S; FAHN S et al.1980; ANN. NEUROL.; USA; DA. 1980; VOL. 8; NO 2; PP. 200; BIBL. 5 REF.Article

EFFECT OF 3',4'-DIHYDROXY-2-METHYL-PROPIOPHENONE (U-0521) ON CATECHOL-O-METHYLTRANSFERASE ACTIVITY AND ON DOPA ACCUMULATION IN RAT RED BLOOD CELLS AND CORPUS STRIATUMRECHES A; DE HUA JIANG; FAHN S et al.1982; BIOCHEMICAL PHARMACOLOGY; ISSN 0006-2952; GBR; DA. 1982; VOL. 31; NO 21; PP. 3415-3418; BIBL. 26 REF.Article

DELAYED-ONSET DYSTONIA IN PATIENTS WITH "STATIC" ENCEPHALOPATHYBURKE RE; FAHN S; GOLD AP et al.1980; J. NEUROL. NEUROSURG. PSYCHIATRY; ISSN 0022-3050; GBR; DA. 1980; VOL. 43; NO 9; PP. 789-797; BIBL. 39 REF.Article

INTERACTION BETWEEN BROMOCRIPTINE AND LEVODOPA. BIOCHEMICAL BASIS FOR AN IMPROVED TREATMENT FOR PARKINSONISM.HUTT CS; SNIDER SR; FAHN S et al.1977; NEUROLOGY; U.S.A.; DA. 1977; VOL. 27; NO 6; PP. 505-510; BIBL. 48 REF.Article

NORMAL ERYTHROCYTE UPTAKE OF L-DOPA IN PARKINSON'S, HUNTINGTON'S, AND RELATED DISEASESDE HUA JIANG; RECHES A; FAHN S et al.1983; NEUROLOGY; ISSN 0028-3878; USA; DA. 1983; VOL. 33; NO 6; PP. 793-796; BIBL. 11 REF.Article

HOMOVANILLIC ACID: ENTRY RATE KINETICS FOR TRANSFER FROM PLASMA TO CEREBROSPINAL FLUID = ACIDE HOMOVANILLIQUE: CINETIQUE DE LA VITESSE D'ENTREE POUR LE TRANSFERT DU PLASMA AU LIQUIDE CEPHALORACHIDIENPROCKOP L; FAHN S; BARBOUR P et al.1974; BRAIN RES.; NETHERL.; DA. 1974; VOL. 80; NO 3; PP. 435-442; BIBL. 16REF.Article